The life science industry in San Diego saw record-breaking venture capital investment activity in the second quarter of the year, according to a report from CBRE. In total, life sciences received $423 million in venture capital investment. In total, the San Diego market received $501 million in venture capital investment, including tech and other sectors. The seven largest deals were in the biotech and pharmaceutical fields, and the largest deal went to Ansun BioPharma, a Torrey Pines-based clinical-stage bio-pharmaceuticals company, which received $85 million. While life science investment was up, tech investment slowed for the quarter. We sat down with Michael Combs, research manager at CBRE, to talk about the investment activity and how it is impacting real estate.

GlobeSt.com: What is driving this tremendous growth in life science investment?

Michael Combs: It is important to highlight that we have seen more investment into life sciences nationally. We are seeing the volume shift that way, and there could be a lot of national and global reasons for that. San Diego is capitalizing on that because it has really been on the cutting edge of some of the key areas of interest, like genomics and new bio-pharmaceutical treatments. Those are areas where a lot of investors are focusing their interest. They are technologies that have the opportunity for huge multiple growth in terms of return but also where larger corporate entities are looking to invest in research and development. San Diego has always been a great place for a lot of the R&D to turn into an acquisition to a larger firm or an agreement or partnership with a larger firm.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Kelsi Maree Borland

Kelsi Maree Borland is a freelance journalist and magazine writer based in Los Angeles, California. For more than 5 years, she has extensively reported on the commercial real estate industry, covering major deals across all commercial asset classes, investment strategy and capital markets trends, market commentary, economic trends and new technologies disrupting and revolutionizing the industry. Her work appears daily on GlobeSt.com and regularly in Real Estate Forum Magazine. As a magazine writer, she covers lifestyle and travel trends. Her work has appeared in Angeleno, Los Angeles Magazine, Travel and Leisure and more.

More from this author

GlobeSt

Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2024 ALM Global, LLC. All Rights Reserved.